Forward Therapeutics, founded in 2022, is a biopharmaceutical company dedicated to transforming the treatment of chronic inflammatory disorders. The company is advancing a pipeline of novel, next-generation small molecule immune therapies.

The company's platform offers a differentiated approach to gene editing in a wide range of cells and tissues, enabling patients to improve their quality of life and extend their lifespan.